A CD38/CD203A/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes

OncoImmunology

Volumn 2, Issue 9, 2013, Pages

  Horenstein, Alberto L ^a,b,c   Chillemi, Antonella ^a,b   Zaccarello, Gianluca ^a,b   Bruzzone, Santina ^d   Quarona, Valeria ^a,b   Zito, Andrea ^a,b   Serra, Sara ^b   Malavasi, Fabio ^a,b,c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Adenosine; CD203a; CD38; Ectonucleotidases; NAD+; PC 1

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; CD38 ANTIGEN; CD39 ANTIGEN; ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOGENICITY; NUCLEOTIDE METABOLISM; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR ESCAPE; TUMOR MICROENVIRONMENT;

EID: 84890276750     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.26246     Document Type: Article

References (65)

1. Lanier LL. Shades of grey--the blurring view of innate and adaptive immunity. Nat Rev Immunol 2013; 13:73-4; PMID:23469373; http://dx.doi. org/10.1038/nri3389
2. Kirschner MW. The meaning of systems biology. Cell 2005; 121:503-4; PMID:15907462; http://dx.doi. org/10.1016/j.cell.2005.05.005
3. Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, Ortolan E, Vaisitti T, Aydin S. Evolution and function of the ADP ribosyl cyclase/ CD38 gene family in physiology and pathology. Physiol Rev 2008; 88:841-86; PMID:18626062; http://dx.doi.org/10.1152/physrev.00035.2007
4. Zimmermann H, Zebisch M, Sträter N. Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal 2012; 8:437-502; PMID:22555564; http://dx.doi.org/10.1007/ s11302-012-9309-4
5. Grahnert A, Grahnert A, Klein C, Schilling E, Wehrhahn J, Hauschildt S. Review: NAD+: a modulator of immune functions. Innate Immun 2011; 17:212-33; PMID:20388721; http://dx.doi. org/10.1177/1753425910361989
6. Ziegler M. New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur J Biochem 2000; 267:1550-64; PMID:10712584; http://dx.doi.org/10.1046/j.1432-1327.2000.01187.x
7. Drury AN, Szent-Györgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 1929; 68:213-37; PMID:16994064
8. Ramakers BP, Wever KE, Kox M, van den Broek PH, Mbuyi F, Rongen G, Masereeuw R, van der Hoeven JG, Smits P, Riksen NP, et al. How systemic inflammation modulates adenosine metabolism and adenosine receptor expression in humans in vivo. Crit Care Med 2012; 40:2609-16; PMID:22732294; http:// dx.doi.org/10.1097/CCM.0b013e318259205b
9. Eltzschig HK, Sitkovsky MV, Robson SC. Purinergic signaling during inflammation. N Engl J Med 2012; 367:2322-33; PMID:23234515; http://dx.doi. org/10.1056/NEJMra1205750
10. Serra S, Horenstein AL, Vaisitti T, Brusa D, Rossi D, Laurenti L, D'Arena G, Coscia M, Tripodo C, Inghirami G, et al. CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death. Blood 2011; 118:6141-52; PMID:21998208; http://dx.doi.org/10.1182/blood-2011-08-374728
11. Sträter N. Ecto-5'-nucleotidase: Structure function relationships. Purinergic Signal 2006; 2:343- 50; PMID:18404474; http://dx.doi.org/10.1007/ s11302-006-9000-8
12. Mandapathil M, Lang S, Gorelik E, Whiteside TL. Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J Immunol Methods 2009; 346:55- 63; PMID:19450601; http://dx.doi.org/10.1016/j. jim.2009.05.004
13. Nikolova M, Carriere M, Jenabian MA, Limou S, Younas M, Kök A, Huë S, Seddiki N, Hulin A, Delaneau O, et al. CD39/adenosine pathway is involved in AIDS progression. PLoS Pathog 2011; 7:e1002110; PMID:21750674; http://dx.doi. org/10.1371/journal.ppat.1002110
14. Chiarugi A, Dölle C, Felici R, Ziegler M. The NAD metabolome--a key determinant of cancer cell biology. Nat Rev Cancer 2012; 12:741-52; PMID:23018234; http://dx.doi.org/10.1038/nrc3340
15. Fruscione F, Scarfì S, Ferraris C, Bruzzone S, Benvenuto F, Guida L, Uccelli A, Salis A, Usai C, Jacchetti E, et al. Regulation of human mesenchymal stem cell functions by an autocrine loop involving NAD+ release and P2Y11-mediated signaling. Stem Cells Dev 2011; 20:1183-98; PMID:20964598; http://dx.doi.org/10.1089/scd.2010.0295
16. Penuela S, Gehi R, Laird DW. The biochemistry and function of pannexin channels. Biochim Biophys Acta 2013; 1828:15-22; PMID:22305965; http:// dx.doi.org/10.1016/j.bbamem.2012.01.017
17. Deterre P, Gelman L, Gary-Gouy H, Arrieumerlou C, Berthelier V, Tixier JM, Ktorza S, Goding J, Schmitt C, Bismuth G. Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-1. Possible role in the recycling of nicotinamide adenine dinucleotide metabolites. J Immunol 1996; 157:1381-8; PMID:8759717
18. Massaia M, Perrin L, Bianchi A, Ruedi J, Attisano C, Altieri D, Rijkers GT, Thompson LF. Human T cell activation. Synergy between CD73 (ecto-5'- nucleotidase) and signals delivered through CD3 and CD2 molecules. J Immunol 1990; 145:1664-74; PMID:1975259
19. Hubert S, Rissiek B, Klages K, Huehn J, Sparwasser T, Haag F, Koch-Nolte F, Boyer O, Seman M, Adriouch S. Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. J Exp Med 2010; 207:2561-8; PMID:20975043; http://dx.doi.org/10.1084/jem.20091154
20. Quarona V, Zaccarello G, Chillemi A, Brunetti E, Singh VK, Ferrero E, Funaro A, Horenstein AL, Malavasi F. CD38 and CD157: a long journey from activation markers to multifunctional molecules. Cytometry B Clin Cytom 2013; 84:207- 17; PMID:23576305; http://dx.doi.org/10.1002/ cyto.b.21092
21. Malavasi F, Funaro A, Roggero S, Horenstein A, Calosso L, Mehta K. Human CD38: a glycoprotein in search of a function. Immunol Today 1994; 15:95-7; PMID:8172650; http://dx.doi. org/10.1016/0167-5699(94)90148-1
22. Goding JW. Ecto-enzymes: physiology meets pathology. J Leukoc Biol 2000; 67:285-311; PMID:10733089
23. Goding JW, Terkeltaub R, Maurice M, Deterre P, Sali A, Belli SI. Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and non-lymphoid cells: structure and function of the PC-1 family. Immunol Rev 1998 161:11-26; PMID:9553761; http://dx.doi. org/10.1111/j.1600-065X.1998.tb01568.x
24. Resta R, Yamashita Y, Thompson LF. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev 1998; 161:95-109; PMID:9553767; ht tp: //dx.doi.org/10.1111/j.1600-065X.1998. tb01574.x
25. Whiteside TL, Jackson EK. Adenosine and prostaglandin e2 production by human inducible regulatory T cells in health and disease. Front Immunol 2013; 4:212; PMID:23898333; http://dx.doi.org/10.3389/ fimmu.2013.00212
26. Sorrentino R, Pinto A, Morello S. The adenosinergic system in cancer: Key therapeutic target. Oncoimmunology 2013; 2:e22448; PMID:23483072; http://dx.doi.org/10.4161/ onci.22448
27. Haskó G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 2008; 7:759- 70; PMID:18758473; http://dx.doi.org/10.1038/ nrd2638
28. Junger WG. Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol 2011; 11:201-12; PMID:21331080; http://dx.doi. org/10.1038/nri2938
29. Kukulski F, Lévesque SA, Sévigny J. Impact of ectoenzymes on p2 and p1 receptor signaling. Adv Pharmacol 2011; 61:263-99; PMID:21586362; http://dx.doi. org/10.1016/B978-0-12-385526-8.00009-6
30. Yegutkin GG. Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim Biophys Acta 2008; 1783:673-94; PMID:18302942; http://dx.doi. org/10.1016/j.bbamcr.2008.01.024
31. Podestà M, Benvenuto F, Pitto A, Figari O, Bacigalupo A, Bruzzone S, Guida L, Franco L, Paleari L, Bodrato N, et al. Concentrative uptake of cyclic ADP-ribose generated by BST-1+ stroma stimulates proliferation of human hematopoietic progenitors. J Biol Chem 2005; 280:5343-9; PMID:15574424; http://dx.doi. org/10.1074/jbc.M408085200
32. Nikiforov A, Dölle C, Niere M, Ziegler M. Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J Biol Chem 2011; 286:21767-78; PMID:21504897; http:// dx.doi.org/10.1074/jbc.M110.213298
33. Di Lisa F, Ziegler M. Pathophysiological relevance of mitochondria in NAD(+) metabolism. FEBS Lett 2001; 492:4-8; PMID:11248227; http://dx.doi. org/10.1016/S0014-5793(01)02198-6
34. Graeff RM, Walseth TF, Fryxell K, Branton WD, Lee HC. Enzymatic synthesis and characterizations of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity. J Biol Chem 1994; 269:30260-7; PMID:7982936
35. Dong RP, Tachibana K, Hegen M, Munakata Y, Cho D, Schlossman SF, Morimoto C. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation. J Immunol 1997; 159:6070-6; PMID:9550406
36. Burnstock G. Discovery of purinergic signalling, the initial resistance and current explosion of interest. Br J Pharmacol 2012; 167:238-55; PMID:22537142; http://dx.doi.org/10.1111/j.1476-5381.2012.02008.x
37. Garavaglia S, Bruzzone S, Cassani C, Canella L, Allegrone G, Sturla L, Mannino E, Millo E, De Flora A, Rizzi M. The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism. Biochem J 2012; 441:131-41; PMID:21933152; http://dx.doi. org/10.1042/BJ20111263
38. Zola H, Swart B, Banham A, Barry S, Beare A, Bensussan A, Boumsell L, D Buckley C, Bühring HJ, Clark G, et al. CD molecules 2006--human cell differentiation molecules. J Immunol Methods 2007; 319:1-5; PMID:17174972; http://dx.doi. org/10.1016/j.jim.2006.11.001
39. Antonioli L, Pacher P, Vizi ES, Haskó G. CD39 and CD73 in immunity and inflammation. Trends Mol Med 2013; 19:355-67; PMID:23601906; http:// dx.doi.org/10.1016/j.molmed.2013.03.005
40. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T. Regulatory T cells: how do they suppress immune responses? Int Immunol 2009; 21:1105-11; PMID:19737784; http://dx.doi. org/10.1093/intimm/dxp095
41. Iqbal J, Zaidi M. Extracellular NAD+ metabolism modulates osteoclastogenesis. Biochem Biophys Res Commun 2006; 349:533-9; PMID:16956582; http://dx.doi.org/10.1016/j.bbrc.2006.08.108
42. Liu Q, Kriksunov IA, Graeff R, Munshi C, Lee HC, Hao Q. Crystal structure of human CD38 extracellular domain. Structure 2005; 13:1331- 9; PMID:16154090; http://dx.doi.org/10.1016/j. str.2005.05.012
43. Ortolan E, Vacca P, Capobianco A, Armando E, Crivellin F, Horenstein A, Malavasi F. CD157, the Janus of CD38 but with a unique personality. Cell Biochem Funct 2002; 20:309-22; PMID:12415565; http://dx.doi.org/10.1002/cbf.978
44. Goding JW, Grobben B, Slegers H. Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochim Biophys Acta 2003; 1638:1-19; PMID:12757929; http://dx.doi.org/10.1016/S0925-4439(03)00058-9
45. Stefan C, Jansen S, Bollen M. NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem Sci 2005; 30:542-50; PMID:16125936; http://dx.doi. org/10.1016/j.tibs.2005.08.005
46. Katada T, Kontani K, Wada T, Hosoda N, Hoshino S, Nishina H. Enzymic and signal transduction properties of CD38/NADase and PC-1/phosphodiesterase. Chem Immunol 2000; 75:60-78; PMID:10851779; http://dx.doi.org/10.1159/000058762
47. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 2006; 112:358- 404; PMID:16784779; http://dx.doi.org/10.1016/j. pharmthera.2005.04.013
48. Grozio A, Sociali G, Sturla L, Caffa I, Soncini D, Salis A, Raffaelli N, De Flora A, Nencioni A, Bruzzone S. CD73 as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells. J Biol Chem 2013; 288:25938-49; PMID:23880765; http://dx.doi.org/10.1074/jbc. M113.470435
49. St Hilaire C, Ziegler SG, Markello TC, Brusco A, Groden C, Gill F, Carlson-Donohoe H, Lederman RJ, Chen MY, Yang D, et al. NT5E mutations and arterial calcifications. N Engl J Med 2011; 364:432- 42; PMID:21288095; http://dx.doi.org/10.1056/ NEJMoa0912923
50. Gracia E, Pérez-Capote K, Moreno E, Barkešová J, Mallol J, Lluís C, Franco R, Cortés A, Casadó V, Canela EI. A2A adenosine receptor ligand binding and signalling is allosterically modulated by adenosine deaminase. Biochem J 2011; 435:701- 9; PMID:21306300; http://dx.doi.org/10.1042/ BJ20101749
51. Gordon EL, Pearson JD, Slakey LL. The hydrolysis of extracellular adenine nucleotides by cultured endothelial cells from pig aorta. Feed-forward inhibition of adenosine production at the cell surface. J Biol Chem 1986; 261:15496-507; PMID:3023320
52. Di Virgilio F. Purines, purinergic receptors, and cancer. Cancer Res 2012; 72:5441-7; PMID:23090120; http://dx.doi.org/10.1158/0008-5472.CAN-12-1600
53. Grobben B, Anciaux K, Roymans D, Stefan C, Bollen M, Esmans EL, Slegers H. An ectonucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma. J Neurochem 1999; 72:826-34; PMID:9930759; http://dx.doi. org/10.1046/j.1471-4159.1999.0720826.x
54. Pavón EJ, Zumaquero E, Rosal-Vela A, Khoo KM, Cerezo-Wallis D, García-Rodríguez S, Carrascal M, Abian J, Graeff R, Callejas-Rubio JL, et al. Increased CD38 expression in T cells and circulating anti- CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients. Cytokine 2013; 62:232-43; PMID:23538292; http://dx.doi. org/10.1016/j.cyto.2013.02.023
55. Horenstein AL, Sizzano F, Lusso R, Besso FG, Ferrero E, Deaglio S, Corno F, Malavasi F. CD38 and CD157 ectoenzymes mark cell subsets in the human corneal limbus. Mol Med 2009; 15:76-84; PMID:19052657; http://dx.doi.org/10.2119/molmed.2008.00108
56. Cecati M, Emanuelli M, Giannubilo SR, Quarona V, Senetta R, Malavasi F, Tranquilli AL, Saccucci F. Contribution of adenosine-producing ectoenzymes to the mechanisms underlying the mitigation of maternal- fetal conflicts. J Biol Regul Homeost Agents 2013; 27:519-29; PMID:23830401
57. Jun JE, Goodnow CC. Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling. Nat Immunol 2003; 4:1057-64; PMID:14586424; http://dx.doi.org/10.1038/ni1001
58. Zhang B. CD73 promotes tumor growth and metastasis. Oncoimmunology 2012; 1:67-70; PMID:22720214; http://dx.doi.org/10.4161/ onci.1.1.18068
59. Ma Y, Adjemian S, Yang H, Catani JP, Hannani D, Martins I, Michaud M, Kepp O, Sukkurwala AQ, Vacchelli E, et al. ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy. Oncoimmunology 2013; 2:e24568; PMID:23894718; http://dx.doi.org/10.4161/ onci.24568
60. Zitvogel L, Galluzzi L, Smyth MJ, Kroemer G. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity 2013; 39:74-88; PMID:23890065; http://dx.doi.org/10.1016/j.immuni.2013.06.014
61. Gutensohn W, Resta R, Misumi Y, Ikehara Y, Thompson LF. Ecto-5'-nucleotidase activity is not required for T cell activation through CD73. Cell Immunol 1995; 161:213-7; PMID:7697732; http:// dx.doi.org/10.1006/cimm.1995.1029
62. Ausiello CM, Urbani F, Lande R, la Sala A, Di Carlo B, Baj G, Surico N, Hilgers J, Deaglio S, Funaro A, et al. Functional topography of discrete domains of human CD38. Tissue Antigens 2000; 56:539-47; PMID:11169244; http://dx.doi. org/10.1034/j.1399-0039.2000.560608.x
63. Horenstein AL, Durelli I, Malavasi F. Purification of clinical-grade monoclonal antibodies by chromatographic methods. Methods Mol Biol 2005; 308:191- 208; PMID:16082036
64. Alessio M, Roggero S, Funaro A, De Monte LB, Peruzzi L, Geuna M, Malavasi F. CD38 molecule: structural and biochemical analysis on human T lymphocytes, thymocytes, and plasma cells. J Immunol 1990; 145:878-84; PMID:1695648
65. Horenstein AL, Stockinger H, Imhof BA, Malavasi F. CD38 binding to human myeloid cells is mediated by mouse and human CD31. Biochem J 1998; 330:1129- 35; PMID:9494077